<a href="https://laohu8.com/S/ATNF">180 Life Sciences Corp</a>. Awards Stock Options to Executives and Directors in Private Placement
180 Life Sciences Corp. recently approved the grant of stock options totaling 965,000 shares of common stock to various members of the company. The breakdown includes 410,000 shares to CEO Blair Jordan, 25,000 shares to Chief Accounting Officer Eric R. Van Lent, 255,000 shares to Lead Director Ryan Smith, 165,000 shares to Director Stephen H. Shoemaker, and 110,000 shares to Director Dr. Lawrence Steinman. These grants were made as consideration for services rendered and to be rendered to the company. The document does not specify the price of these transactions.
Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. 180 Life Sciences Corp. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001213900-25-056232), on June 20, 2025, and is solely responsible for the information contained therein.
免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。